Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases
Description
Hematopoietic stem cell transplant (HSCT) recipients may be at high risk of mortality from coronavirus disease 2019 (COVID-19). However, specific data on COVID-19 after treatment with HSCT in patients affected by autoimmune diseases (ADs) are still
